New research explores how virus-specific T-cell therapy may help prevent or treat cytomegalovirus after transplant, revealing high response rates in HSCT patients but limited data in solid organ ...

Several medications for CMV treatment are under study, including vaccines that show promise in preventing infection. Current ...

A new study led by scientists at the University of Oxford has revealed something surprising: a common virus carried by more ...

Cytomegalovirus (CMV), a beta-herpesvirus capable of maintaining lifelong latency, presents a substantial risk to transplant recipients, resulting in significant morbidity and mortality among both ...